Fennec Pharma Net income (Q2, 2018)-4.2 M
Fennec Pharma EBIT (Q2, 2018)-4.5 M
Fennec Pharma Cash, 30-Jun-201825.6 M

Fennec Pharma Income Statement

Annual

USDFY, 2016FY, 2017

Revenue

R&D expense

472.0k1.9m

General and administrative expense

2.4m5.0m

Operating expense total

2.9m7.0m

EBIT

(2.9m)(7.0m)

Net Income

(2.8m)(7.0m)

Quarterly

USDQ3, 2013Q1, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Revenue

R&D expense

224.0k32.0k88.0k54.0k88.0k47.0k139.0k112.0k225.0k333.0k492.0k689.0k1.5m

General and administrative expense

275.0k505.0k531.0k409.0k495.0k250.0k407.0k568.0k452.0k546.0k1.1m1.7m1.1m3.0m

Operating expense total

51.0k537.0k619.0k409.0k549.0k338.0k454.0k707.0k564.0k771.0k1.5m2.2m1.8m4.5m

EBIT

(51.0k)(537.0k)(619.0k)(452.0k)(549.0k)(338.0k)(454.0k)(707.0k)(564.0k)(771.0k)(1.5m)(2.2m)(1.8m)(4.5m)

Interest income

3.0k

Net Income

(1.8m)(3.2m)380.0k177.0k(806.0k)(1.6m)(2.4m)(1.6m)(4.2m)

Fennec Pharma Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

1.7m2.3m942.0k3.9m28.3m

Total Assets

1.8m2.4m1.0m4.0m28.4m

Accounts Payable

212.0k308.0k297.0k244.0k855.0k

Current Liabilities

3.2m1.8m471.0k402.0k1.6m

Total Liabilities

3.2m471.0k402.0k1.6m

Additional Paid-in Capital

39.2m41.6m41.7m42.1m43.8m

Retained Earnings

(110.9m)(111.5m)(114.3m)(121.4m)

Total Equity

548.0k3.6m26.8m

Financial Leverage

1.9 x1.1 x1.1 x

Quarterly

USDQ3, 2013Q1, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Cash

538.0k1.3m593.0k1.9m1.9m1.4m545.0k5.1m4.5m3.3m10.2m9.7m26.7m25.6m

Total Assets

640.0k1.4m673.0k1.9m1.9m1.5m588.0k5.1m4.6m3.3m10.3m9.9m26.8m25.7m

Accounts Payable

315.0k154.0k364.0k384.0k401.0k252.0k225.0k345.0k235.0k224.0k296.0k492.0k1.0m709.0k

Current Liabilities

5.7m3.9m1.1m759.0k431.0k345.0k451.0k360.0k427.0k580.0k1.0m1.2m847.0k

Total Liabilities

4.8m5.7m3.9m345.0k360.0k580.0k1.0m1.2m847.0k

Additional Paid-in Capital

38.5m39.5m41.0m41.6m41.6m41.6m41.7m41.8m41.9m42.2m42.9m43.6m44.0m45.1m

Retained Earnings

(110.7m)(110.9m)(111.0m)(112.0m)(112.7m)(113.2m)(115.1m)(116.7m)(119.1m)(122.9m)(125.5m)

Total Equity

1.1m1.0m243.0k4.7m4.2m2.9m9.7m8.9m25.7m24.9m

Financial Leverage

1.7 x1.4 x2.4 x1.1 x1.1 x1.1 x1.1 x1.1 x1 x1 x

Fennec Pharma Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

1.8m(2.8m)(7.0m)

Accounts Payable

(11.0k)(54.0k)611.0k

Cash From Operating Activities

(2.2m)(1.7m)(1.9m)(2.1m)(3.6m)

Cash From Financing Activities

2.3m497.0k5.1m28.0m

Quarterly

USDQ3, 2013Q1, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Net Income

(1.8m)(3.2m)380.0k177.0k(420.0k)(502.0k)(806.0k)(1.6m)(2.4m)(1.6m)(4.2m)

Accounts Payable

384.0k401.0k252.0k(72.0k)345.0k(110.0k)224.0k71.0k196.0k178.0k(146.0k)

Cash From Operating Activities

(469.0k)(378.0k)(443.0k)(499.0k)(544.0k)(688.0k)(958.0k)(1.7m)(3.3m)

Cash From Financing Activities

53.0k21.0k102.0k7.7m414.0k186.0k677.0k

Fennec Pharma Ratios

USDY, 2018

Financial Leverage

1 x
Report incorrect company information